Gauthier Pouliquen

This inventor holds 8 USPTO granted patents and 7 published patent applications, plus 2 CIPO patents and 4 EPO patents. Top assignees: Flamel Ireland Limited, Flamel Technologies, Ares Trading S.a.. Active years: 2011-2021.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Gauthier Pouliquen. Retrieved from https://idiyas.com/inventor/gauthier-pouliquen

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 8 (Patent Applications = 7)

% Patents Active = 75.0

CIPO Patents = 2 (Patent Applications = 3)

EPO Patents = 4 (Patent Applications = 6)

Average Co-Inventor Count = 4.7

ph-index = 4

Forward Citations = 117(Granted Patents)

Location History:

Lyons, FR (2011 - 2018)
Ternay, FR (2016 - 2021)

Company Filing History:

3 out of 60

Flamel Ireland Limited

Avadel Legacy Pharmaceuticals, LLC

patent

5. 1 out of 5

Exela Sterile Medicines LLC

patents

Years Active: 2011-2021

Loading Chart...

8 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11045438 - Cysteine composition and injection (2021-06-29),

2. 10702490 - Cysteine composition and injection (2020-07-07),

3. 10543186 - Cysteine composition and injection (2020-01-28),

4. 10493051 - Cysteine composition and injection (2019-12-03),

5. 10052289 - Composition comprising an active agent with low aqueous solubility (2018-08-21),

6. 9272020 - IFN-beta compositions, preparation methods and uses thereof (2016-03-01),

7. 8206744 - Branched polyamino acids functionalized with hydrophobic groups, and applications thereof particularly therapeutic applications (2012-06-26),

8. 8084045 - Pharmaceutical formulations for the prolonged release of active principle(s) and their applications (2011-12-27),

Title: Gauthier Pouliquen: Innovator in Cysteine Compositions

Introduction

Gauthier Pouliquen is a notable inventor based in Ternay, France. He has made significant contributions to the field of pharmaceutical compositions, particularly focusing on cysteine solutions. With a total of eight patents to his name, Pouliquen's work has the potential to impact nutritional requirements in medical settings.

Latest Patents

Among his latest patents is a composition for cysteine injection. This invention involves cysteine compositions that contain less than about 400 µg/L of aluminum. The solutions are designed to be devoid of visible particulate matter and may be suitable for injection. Specifically, these cysteine solutions can be administered intravenously to meet the amino acid nutritional requirements of individuals receiving total parenteral nutrition. Additionally, the patent outlines processes for preparing these cysteine compositions and methods for providing cysteine to individuals in need.

Career Highlights

Gauthier Pouliquen has worked with several companies throughout his career, including Flamel Ireland Limited and Flamel Technologies. His experience in these organizations has contributed to his expertise in developing innovative pharmaceutical solutions.

Collaborations

Some of his notable coworkers include Angela Sutterer and Jill Simpson. Their collaboration has likely played a role in advancing the research and development of cysteine compositions.

Conclusion

Gauthier Pouliquen's contributions to the field of cysteine compositions highlight his innovative spirit and dedication to improving nutritional solutions in medical care. His patents reflect a commitment to enhancing the quality of life for individuals requiring specialized nutritional support.

Profile summary based on public USPTO records.